The FDA has approved MediBeacon®'s TGFR system for noninvasive kidney function assessment, targeting both normal and impaired renal patients. INNOVATE Corp. announced the FDA approval of the ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Palopegteriparatide improved skeletal dynamics and renal ...

A new trial has found that patient management through remote means could reduce all-cause mortality and hospitalizations for heart failure (HF) in patients with renal impairment. Patients with heart ...

Please provide your email address to receive an email when new articles are posted on . In the United States, the annual rate of growth in incident patients with end-stage kidney disease has slowed.